Chemical Structure : FKA-9i
Catalog No.: PC-27293Not For Human Use, Lab Use Only.
FKA-9i is a potent broad-spectrum anticancer agent, directly binds to leucine-rich PPR motif-containing protein (LRPPRC), Y-box binding protein 1 (YBX1), and ribophorin I (RPN1) with 7.387 μM, 26.82 μM, and 16.52 μM, respectively, reducing their interactions and stability.
Bulk size, bulk discount!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
FKA-9i is a potent broad-spectrum anticancer agent, directly binds to leucine-rich PPR motif-containing protein (LRPPRC), Y-box binding protein 1 (YBX1), and ribophorin I (RPN1) with 7.387 μM, 26.82 μM, and 16.52 μM, respectively, reducing their interactions and stability.
FKA-9i impedes cancer progression via LRPPRC-YBX1-RPN1 mediated MAPK signaling pathway.
FKA-9i induces cancer cell cycle arrest, apoptosis, and mitochondrial dysfunction characterized by suppressed oxidative phosphorylation (OXPHOS) and accumulated reactive oxygen species (ROS).
FKA-9i exhibits a synergistic enhancement effect when combined with chemotherapeutic drugs, YBX1 and RPN1 inhibitors, as well as drugs targeting the glycolysis pathway.
| M.Wt | 660.66 | |
| Formula | C30H26F2N2O9S2 | |
| Appearance | Solid | |
| Storage |
|
|
| Solubility |
10 mM in DMSO |
|
1. Rui Wu, et al. Bioorg Chem. 2026 Mar:170:109425.

Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright